About this trial
This is a multicentre prospective cohort study where patients will receive up to 14 days of continuous ECG monitoring by wearing a portable monitoring device, starting within 72 hours after noncardiac surgery.
Eligibility criteria
Qualifiers
an overnight hospital admission after surgery
day surgery that would result in a large enough physiological insult to be able to cause POAF. Procedures excluded include those that are conducted using local anesthesia alone, are less than 30 minutes in duration, and/or are judged to be of low physiologic insult by the local investigator.
Have one of the following high-risk criteria;
age 55-64 years, and having either established cardiovascular disease, recent major vascular surgery, a CHA2DS2-VASc score ≥3, or an elevated postoperative troponin level;
Disqualifiers
History of documented chronic (i.e., non-transient) AF before noncardiac surgery;
Need for long-term systemic anticoagulation;
Ongoing need for long-term dual antiplatelet treatment;
Contraindication to oral anticoagulation;
Trial design
Treatments tested in this trial
- Cardiac monitoring device